Literature DB >> 30714803

The effects of clavulanic acid and amoxicillin on cue-primed reinstatement of cocaine seeking.

Allison R Bechard1, Peter U Hamor1, Lizhen Wu1, Marek Schwendt1, Lori A Knackstedt1.   

Abstract

Research using the cocaine self-administration and reinstatement animal model of relapse finds that the beta-lactam antibiotic, ceftriaxone, attenuates cocaine-primed reinstatement of cocaine seeking and upregulates two proteins that regulate glutamate release and reuptake (xCT and GLT-1, respectively) in the nucleus accumbens core (NAc). We tested three compounds with beta-lactam rings for their ability to attenuate cue-primed reinstatement and increase GLT-1 and xCT expression in the NAc and prefrontal cortex (PFC). Rats self-administered intravenous cocaine for 1 hr/day for 7 days then 6 hrs/day for 10 days. Cue-primed reinstatement tests began after 8-9 days of extinction training. Rats received oral vehicle, clavulanic acid (CA), amoxicillin (AMX), or CA + AMX (Augmentin; AUG) for 5 days prior to testing. Only AMX-treated rats demonstrated a reduction of cocaine-seeking that trended toward significance, warranting future investigation of a wider range of doses. In the NAc, GLT-1a expression was reduced in vehicle-treated rats relative to cocaine-naïve controls and was not restored by AMX or AUG. CA-treated rats reinstated more than vehicle-treated rats and exhibited GLT-1a and xCT expression intermediate between cocaine-naïve controls and vehicle-treated cocaine rats. In agreement with our previous work, cocaine did not decrease PFC GLT-1a expression. Cocaine reduced xCT expression in the PFC that was unchanged by any of the three compounds. These results indicate that AMX may be another beta-lactam that attenuates cocaine relapse. Furthermore, the upregulation of both GLT-1 and xCT in the NAc may be needed to attenuate cocaine seeking. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30714803      PMCID: PMC6508097          DOI: 10.1037/bne0000297

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  21 in total

Review 1.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.

Authors:  David H Epstein; Kenzie L Preston; Jane Stewart; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

2.  Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement.

Authors:  Kathryn J Reissner; Cassandra D Gipson; Phuong K Tran; Lori A Knackstedt; Michael D Scofield; Peter W Kalivas
Journal:  Addict Biol       Date:  2014-02-25       Impact factor: 4.280

3.  Clavulanic acid induces penile erection and yawning in male rats: comparison with apomorphine.

Authors:  Fabrizio Sanna; Maria Rosaria Melis; Laura Angioni; Antonio Argiolas
Journal:  Pharmacol Biochem Behav       Date:  2012-12-09       Impact factor: 3.533

4.  Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

Authors:  Jeffrey D Rothstein; Sarjubhai Patel; Melissa R Regan; Christine Haenggeli; Yanhua H Huang; Dwight E Bergles; Lin Jin; Margaret Dykes Hoberg; Svetlana Vidensky; Dorothy S Chung; Shuy Vang Toan; Lucie I Bruijn; Zao-Zhong Su; Pankaj Gupta; Paul B Fisher
Journal:  Nature       Date:  2005-01-06       Impact factor: 49.962

5.  Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats.

Authors:  Youssef Sari; Kathryn D Smith; Pir K Ali; George V Rebec
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

6.  Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking.

Authors:  Lori A Knackstedt; Roberto I Melendez; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

7.  The effects of varied extinction procedures on contingent cue-induced reinstatement in Sprague-Dawley rats.

Authors:  Deanne M Buffalari; Matthew W Feltenstein; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2013-06-18       Impact factor: 4.530

8.  Ceftriaxone normalizes nucleus accumbens synaptic transmission, glutamate transport, and export following cocaine self-administration and extinction training.

Authors:  Heather Trantham-Davidson; Ryan T LaLumiere; Kathryn J Reissner; Peter W Kalivas; Lori A Knackstedt
Journal:  J Neurosci       Date:  2012-09-05       Impact factor: 6.167

9.  Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization.

Authors:  Lori A Knackstedt; Peter W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  2007-06-29       Impact factor: 4.030

10.  Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking.

Authors:  Ana Weiland; Steven Garcia; Lori A Knackstedt
Journal:  Front Pharmacol       Date:  2015-03-10       Impact factor: 5.810

View more
  5 in total

1.  Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

2.  The GLT-1 enhancer clavulanic acid suppresses cocaine place preference behavior and reduces GCPII activity and protein levels in the rat nucleus accumbens.

Authors:  Helene L Philogene-Khalid; Mary F Morrison; Nune Darbinian; Michael E Selzer; Joseph Schroeder; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2022-01-12       Impact factor: 4.492

3.  MC-100093, a Novel β-Lactam Glutamate Transporter-1 Enhancer Devoid of Antimicrobial Properties, Attenuates Cocaine Relapse in Rats.

Authors:  Lori A Knackstedt; Lizhen Wu; Jeffrey Rothstein; Svetlana Vidensky; John Gordon; Mercy Ramanjulu; Paul Dunman; Benjamin Blass; Wayne Childers; Magid Abou-Gharbia
Journal:  J Pharmacol Exp Ther       Date:  2021-05-13       Impact factor: 4.402

Review 4.  Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.

Authors:  Kathryn D Fischer; Lori A Knackstedt; Paul A Rosenberg
Journal:  Neurochem Int       Date:  2020-11-05       Impact factor: 3.921

Review 5.  N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research.

Authors:  Irena Smaga; Małgorzata Frankowska; Małgorzata Filip
Journal:  Pharmacol Rep       Date:  2021-06-06       Impact factor: 3.024

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.